[This corrects the article DOI: 10.3389/fonc.2023.1127645.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10968889 | PMC |
| http://dx.doi.org/10.3389/fonc.2024.1348105 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "ROCK inhibition reduces the sensitivity of mutant p53 glioblastoma to genotoxic stress through a Rac1- driven ROS production" [Int. J. Biochem. Mol. Bio. 164 (2023) 106474-106484].
Int J Biochem Cell Biol
January 2025
Laboratory of Signaling in Biomolecular Systems, Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil. Electronic address:
Corrigendum to "Varieties of Interactions of anti-CD133 Aptamers with Cell Cultures from Patient Glioblastoma" [SLAS Discov. 2024 Nov 16;29(8):100195].
SLAS Discov
December 2024
Lomonosov Moscow State University, Moscow, Russia; N.N. Burdenko National Medical Research Center of Neurosurgery, Ministry of Health, Moscow, Russia. Electronic address:
Corrigendum to 'UCP2 silencing in glioblastoma reduces cell proliferation and invasiveness by inhibiting p38 MAPK pathway' [Exp. Cell Res. 394 (2020) 112110].
Exp Cell Res
November 2024
Glioma Surgery Division, Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, 200040, China. Electronic address:
Corrigendum: 5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells.
Front Oncol
September 2024
Department of Immunology, Binzhou Medical University, Yantai, China.
[This corrects the article DOI: 10.3389/fonc.2023.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!